Katherine E. Harris

2.9k total citations
35 papers, 1.7k citations indexed

About

Katherine E. Harris is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Katherine E. Harris has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Cardiology and Cardiovascular Medicine and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Katherine E. Harris's work include CAR-T cell therapy research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Blood Pressure and Hypertension Studies (8 papers). Katherine E. Harris is often cited by papers focused on CAR-T cell therapy research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Blood Pressure and Hypertension Studies (8 papers). Katherine E. Harris collaborates with scholars based in United States, Norway and Finland. Katherine E. Harris's co-authors include Jonathan M. Edelman, Markku S. Nieminen, Richard B. Devereux, Sverre E. Kjeldsen, Kristian Wachtell, Stevo Julius, Björn Dahlöf, Peter M. Okin, Sverker Jern and Eva Gerdts and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Katherine E. Harris

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine E. Harris United States	20	1.1k	319	280	217	204	35	1.7k
Christian Gerdes Denmark	23	630 0.6×	423 1.3×	283 1.0×	381 1.8×	224 1.1×	87	2.0k
Joji Nitobe Japan	21	815 0.7×	87 0.3×	184 0.7×	366 1.7×	76 0.4×	46	1.4k
Monica Maria Pagliara Italy	16	187 0.2×	436 1.4×	227 0.8×	217 1.0×	223 1.1×	52	1.4k
Mikio Mukai Japan	21	343 0.3×	485 1.5×	75 0.3×	321 1.5×	83 0.4×	70	1.3k
Ken‐ichi Miyoshi Japan	20	356 0.3×	123 0.4×	86 0.3×	410 1.9×	54 0.3×	63	1.3k
Naoki Watanabe Japan	18	573 0.5×	59 0.2×	321 1.1×	463 2.1×	168 0.8×	67	1.4k
Christopher Madias United States	20	896 0.8×	54 0.2×	199 0.7×	395 1.8×	379 1.9×	67	1.9k
H. G. Rennke United States	19	381 0.3×	247 0.8×	63 0.2×	474 2.2×	72 0.4×	32	1.7k
Xiaoteng Ma China	14	374 0.3×	176 0.6×	112 0.4×	297 1.4×	180 0.9×	66	1.0k
Teruaki Imada Japan	21	730 0.6×	124 0.4×	46 0.2×	512 2.4×	124 0.6×	56	1.6k

Countries citing papers authored by Katherine E. Harris

Since Specialization

Citations

This map shows the geographic impact of Katherine E. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Harris more than expected).

Fields of papers citing papers by Katherine E. Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Harris. The network helps show where Katherine E. Harris may publish in the future.

Co-authorship network of co-authors of Katherine E. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Harris. A scholar is included among the top collaborators of Katherine E. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Harris. Katherine E. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manley, Thomas, Starlynn Clarke, Manpreet Kaur, et al.. (2025). A novel CD28 x Nectin-4 costimulatory bispecific antibody for advanced bladder cancer.. Journal of Clinical Oncology. 43(5_suppl). 810–810. 1 indexed citations

Kaur, Manpreet, Udaya S. Rangaswamy, Laura Davison, et al.. (2025). Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers. Journal for ImmunoTherapy of Cancer. 13(4). e011323–e011323.

Harris, Katherine E., James L. LaBelle, & Michael R. Bishop. (2021). Current Status of CAR T Cell Therapy for Leukemias. Current Treatment Options in Oncology. 22(7). 62–62. 12 indexed citations

Wagner, Andrew J., Vinod Ravi, Richard F. Riedel, et al.. (2020). Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT.. Journal of Clinical Oncology. 38(15_suppl). 11516–11516. 13 indexed citations

Buelow, Ben, Kevin Dang, Pranjali Dalvi, et al.. (2020). Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e17583–e17583. 1 indexed citations

Buelow, Ben, Starlynn Clarke, Kevin Dang, et al.. (2018). Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma.. Journal of Clinical Oncology. 36(15_suppl). 8034–8034. 19 indexed citations

Buelow, Ben, Duy Pham, Starlynn Clarke, et al.. (2017). Development of a fully human T cell engaging bispecific antibody for the treatment of multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). 8017–8017. 5 indexed citations

Harris, Katherine E., Nikolai Schnittke, & Steven K. Beckendorf. (2007). Two ligands signal through the Drosophila PDGF/VEGF receptor to ensure proper salivary gland positioning. Mechanisms of Development. 124(6). 441–448. 23 indexed citations

Okin, Peter M., Richard B. Devereux, Katherine E. Harris, et al.. (2007). In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients. Hypertension. 50(5). 984–990. 35 indexed citations

10.

Okin, Peter M., Kristian Wachtell, Richard B. Devereux, et al.. (2006). Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension. JAMA. 296(10). 1242–1242. 176 indexed citations

11.

Okin, Peter M., Richard B. Devereux, Eva Gerdts, et al.. (2006). Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy. Circulation. 113(12). 1588–1596. 59 indexed citations

12.

Kjeldsen, Sverre E., Paulette A. Lyle, Jorge R. Kizer, et al.. (2005). The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study. Journal of Clinical Hypertension. 7(3). 152–158. 30 indexed citations

13.

Denver, Dee R., Krystalynne Morris, Katherine E. Harris, et al.. (2004). Abundance, Distribution, and Mutation Rates of Homopolymeric Nucleotide Runs in the Genome of Caenorhabditis elegans. Journal of Molecular Evolution. 58(5). 584–595. 55 indexed citations

14.

Julius, Stevo, Michael H. Alderman, Gareth Beevers, et al.. (2004). Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy. Journal of the American College of Cardiology. 43(6). 1047–1055. 98 indexed citations

15.

Kizer, Jorge R., Björn Dahlöf, Sverre E. Kjeldsen, et al.. (2004). Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol. Hypertension. 45(1). 46–52. 72 indexed citations

16.

Ramaciotti, Claudio, et al.. (2003). Echocardiographic Diagnosis of Anomalous Drainage of the Superior Vena Cava Into the Left Atrium. Circulation. 107(11). 1560–1561. 9 indexed citations

17.

Zheng, Jie, Debiao Li, Friedrich Cavagna, et al.. (2001). Contrast‐enhanced coronary MR angiography: Relationship between coronary artery delineation and blood T1. Journal of Magnetic Resonance Imaging. 14(4). 348–354. 10 indexed citations

18.

Zheng, Jie, James Carr, Katherine E. Harris, et al.. (2001). Three‐dimensional MR pulmonary perfusion imaging and angiography with an injection of a new blood pool contrast agent B‐22956/1. Journal of Magnetic Resonance Imaging. 14(4). 425–432. 17 indexed citations

19.

Cohen, Marc, Pierre Théroux, Simon Weber, et al.. (1999). Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. International Journal of Cardiology. 71(3). 273–281. 57 indexed citations

20.

Swanson, Brian N., Peter H. Vlasses, R Ferguson, et al.. (1984). Influence of Food on the Bioavailability of Enalapril. Journal of Pharmaceutical Sciences. 73(11). 1655–1657. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact